Horizon Therapeutics (Formally Known as Horizon Pharma)
Pharmaceutical company.
Based in DC
🤖
AI Overview
With $1.4M in lobbying spend across 23 quarterly filings, Horizon Therapeutics (Formally Known as Horizon Pharma) is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2019 to 2023.
$1.4M
Total Spend
5
Years Active
1
Firms Hired
5
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $200K |
| 2020 | $240K |
| 2021 | $240K |
| 2022 | $440K |
| 2023 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Issues related to the Orphan Drug Act
- •H Res 242 "Affirming the importance of the Orphan Drug Act"
- •The SPIKE Act; Prescription Drug Pricing Classification
- •General orphan drug policy
- •SPIKE Act; Prescription Drug Classification
- •General orphan drug policy;
- •Thyroid Eye Disease
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.